Genetic alterations in MED12 promote castration-resistant prostate cancer through modulation of GLI3 signaling

Schematic diagram of working model. In the absence of androgen, the SHH signaling pathway is turned on leading to an upregulation of the downstream effector GLI3. In the presence of wildtype MED12 (left), a constraint is placed on GLI3 signaling thereby leading to regulated GLI3 target gene expression and a subsequent block to progression towards CRPC. When MED12 is either downregulated or mutated (right), the constraint on GLI3 is lifted thereby leading to hyperactivated GLI3 target gene expression and subsequent progression to CRPC.
Genetic alterations in MED12 promote castration-resistant prostate cancer through modulation of GLI3 signaling

Publication

Genetic alterations in MED12 promote castration-resistant prostate cancer through modulation of GLI3 signaling. (2023) Thu Minh Duong, et al. Mol Biol Res Commun. 2023;12(2):63-70. Figure: F5.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates GLS GLS ncbigene_symbol GLS 2744
Homo sapiens Primates GLS GLS ncbigene_synonym GLS2 27165
Homo sapiens Primates GLI3 GLI3 ncbigene_symbol GLI3 2737
Homo sapiens Primates por POR ncbigene_symbol POR 5447
Homo sapiens Primates por POR ncbigene_synonym VDAC2 7417

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID